Serum Levels of Leptin As Marker For Patients At High Risk of Gastric Cancer

L. Capelle,A. D. de Vries,J. Haringsma,E. Steyerberg,Caspar W. N. Looman,N. Nagtzaam,H. van Dekken,F. Ter Borg,R. A. de Vries,E. Kuipers
DOI: https://doi.org/10.1111/j.1523-5378.2009.00728.x
2009-12-01
Helicobacter
Abstract:Background:  Serological screening for gastric cancer (GC) may reduce mortality. However, optimal serum markers for advanced gastric precursor lesions are lacking.
What problem does this paper attempt to address?